Abstract: Cationic or zwitterionic polymer adhesives, adhesive articles, aqueous polymerizable pre-adhesive reaction mixtures, and methods of preparation that include internal incorporation of a hydrocarbon tackifier. An aqueous polymerizable pre-adhesive reaction mixture includes one or more cationic (meth)acrylate monomers, one or more low Tg nonionic monomers having a (meth)acryloyl group, optionally one or more anionic (meth)acrylate monomers, and one or more hydrocarbon tackifiers.

Abstract: Cationic or zwitterionic polymer adhesives, adhesive articles, aqueous polymerizable pre-adhesive reaction mixtures, and methods of preparation that include internal incorporation of a phenolic resin. The aqueous polymerizable pre-adhesive reaction mixtures include one or more cationic (meth)acrylate monomers, one or more low Tg nonionic monomer having a (meth)acryloyl group, optionally one or more anionic (meth)acrylate monomers, and one or more phenolic resins.

Abstract: An adhesive article for masking a portion of a substrate surface from a liquid coating applied to the surface includes a support having first and second opposed major surfaces, and a cationic or zwitterionic adhesive composition disposed on at least a portion of at least one of the first and second opposed major surfaces. The adhesive composition provides a barrier that impedes the migration of the coating past the edge of the adhesive article.

Abstract: An adhesive article for masking a portion of a substrate surface from a liquid coating applied to the surface includes a support having first and second opposed major surfaces, and a cationic or zwitterionic adhesive composition disposed on at least a portion of at least one of the first and second opposed major surfaces. The adhesive composition provides a barrier that impedes the migration of the coating past the edge of the adhesive article.

Abstract: Cationic or zwitterionic polymer adhesives, adhesive articles, aqueous polymerizable pre-adhesive reaction mixtures, and methods of preparation that include internal incorporation of a phenolic resin. The aqueous polymerizable pre-adhesive reaction mixtures include one or more cationic (meth)acrylate monomers, one or more low Tg nonionic monomer having a (meth)acryloyl group, optionally one or more anionic (meth)acrylate monomers, and one or more phenolic resins.

Abstract: Cationic or zwitterionic polymer adhesives, adhesive articles, aqueous polymerizable pre-adhesive reaction mixtures, and methods of preparation that include internal incorporation of a phenolic resin. The aqueous polymerizable pre-adhesive reaction mixtures include one or more cationic (meth)acrylate monomers, one or more low Tg nonionic monomer having a (meth)acryloyl group, optionally one or more anionic (meth)acrylate monomers, and one or more phenolic resins.

Abstract: Cationic or zwitterionic polymer adhesives, adhesive articles, aqueous polymerizable pre-adhesive reaction mixtures, and methods of preparation that include internal incorporation of a hydrocarbon tackifier. An aqueous polymerizable pre-adhesive reaction mixture includes one or more cationic (meth)acrylate monomers, one or more low Tg nonionic monomers having a (meth)acryloyl group, optionally one or more anionic (meth)acrylate monomers, and one or more hydrocarbon tackifiers.

Abstract: A stable transdermal adhesive composition comprising: an adhesive comprising a washed polymerization reaction product of at least two ethylenically unsaturated monomers; and at least one pharmaceutically active compound which is susceptible to oxidative degradation; wherein the at least two ethylenically unsaturated monomers, if present in the adhesive as unreacted monomers, are present at a level of less than 200 ppm of total unreacted monomer, based upon the total weight of the adhesive, methods of making the composition, a transdermal drug delivery device using the composition, methods of making the device, and methods of delivery the pharmaceutically active compound are provided.

Abstract: Cationic or zwitterionic polymer adhesives, adhesive articles, aqueous polymerizable pre-adhesive reaction mixtures, and methods of preparation that include internal incorporation of a phenolic resin. The aqueous polymerizable pre-adhesive reaction mixtures include one or more cationic (meth)acrylate monomers, one or more low Tg nonionic monomer having a (meth)acryloyl group, optionally one or more anionic (meth)acrylate monomers, and one or more phenolic resins.

Abstract: A stable transdermal adhesive composition comprising: an adhesive comprising a washed polymerization reaction product of at least two ethylenically unsaturated monomers; and at least one pharmaceutically active compound which is susceptible to oxidative degradation; wherein the at least two ethylenically unsaturated monomers, if present in the adhesive as unreacted monomers, are present at a level of less than 200 ppm of total unreacted monomer, based upon the total weight of the adhesive, methods of making the composition, a transdermal drug delivery device using the composition, methods of making the device, and methods of delivery the pharmaceutically active compound are provided.

Abstract: A stable transdermal adhesive composition comprising: an adhesive comprising a washed polymerization reaction product of at least two ethylenically unsaturated monomers; and at least one pharmaceutically active compound which is susceptible to oxidative degradation; wherein the at least two ethylenically unsaturated monomers, if present in the adhesive as unreacted monomers, are present at a level of less than 200 ppm of total unreacted monomer, based upon the total weight of the adhesive, methods of making the composition, a transdermal drug delivery device using the composition, methods of making the device, and methods of delivery the pharmaceutically active compound are provided.

Abstract: An adhesive article for masking a portion of a substrate surface from a liquid coating applied to the surface includes a support having first and second opposed major surfaces, and a cationic or zwitterionic adhesive composition disposed on at least a portion of at least one of the first and second opposed major surfaces. The adhesive composition provides a barrier that impedes the migration of the coating past the edge of the adhesive article.

Abstract: An adhesive article for masking a portion of a substrate surface from a liquid coating applied to the surface includes a support having first and second opposed major surfaces, and a cationic or zwitterionic adhesive composition disposed on at least a portion of at least one of the first and second opposed major surfaces. The adhesive composition provides a barrier that impedes the migration of the coating past the edge of the adhesive article.

Abstract: An antimicrobial pressure-sensitive adhesive (PSA). The PSA system can include an antimicrobial polymer having a plurality of pendant groups. The plurality of pendant groups can include (i) a first pendant group comprising a nonpolar compound, (ii) a second pendant group comprising a quaternary ammonium compound, and (iii) a third pendant group different from the first pendant group or the second pendent group, wherein the third pendant group provides inter-reactivity, such that the antimicrobial polymer can include one or more intermolecular interactions. The antimicrobial polymer can be free of non-ionic hydrophilic moieties. The PSA system can have a glass transition temperature Tg ranging from 0 to 50 degrees C.

Abstract: A stable transdermal adhesive composition comprising: an adhesive comprising a washed polymerization reaction product of at least two ethylenically unsaturated monomers; and at least one pharmaceutically active compound which is susceptible to oxidative degradation; wherein the at least two ethylenically unsaturated monomers, if present in the adhesive as unreacted monomers, are present at a level of less than 200 ppm of total unreacted monomer, based upon the total weight of the adhesive, methods of making the composition, a transdermal drug delivery device using the composition, methods of making the device, and methods of delivery the pharmaceutically active compound are provided.

Abstract: A stable transdermal adhesive composition comprising: an adhesive comprising a washed polymerization reaction product of at least two ethylenically unsaturated monomers; and at least one pharmaceutically active compound which is susceptible to oxidative degradation; wherein the at least two ethylenically unsaturated monomers, if present in the adhesive as unreacted monomers, are present at a level of less than 200 ppm of total unreacted monomer, based upon the total weight of the adhesive, methods of making the composition, a transdermal drug delivery device using the composition, methods of making the device, and methods of delivery the pharmaceutically active compound are provided.

Abstract: An adhesive article for masking a portion of a substrate surface from a liquid coating applied to the surface includes a support having first and second opposed major surfaces, and a cationic or zwitterionic adhesive composition disposed on at least a portion of at least one of the first and second opposed major surfaces. The adhesive composition provides a barrier that impedes the migration of the coating past the edge of the adhesive article.

Abstract: A stable transdermal adhesive composition comprising: an adhesive comprising a washed polymerization reaction product of at least two ethylenically unsaturated monomers; and at least one pharmaceutically active compound which is susceptible to oxidative degradation; wherein the at least two ethylenically unsaturated monomers, if present in the adhesive as unreacted monomers, are present at a level of less than 200 ppm of total unreacted monomer, based upon the total weight of the adhesive, methods of making the composition, a transdermal drug delivery device using the composition, methods of making the device, and methods of delivery the pharmaceutically active compound are provided.

Abstract: Embodiments of the invention include devices and methods for the controlled elution of nucleic acid delivery complexes. In an embodiment, the invention includes a method of making a medical device. The method can include complexing nucleic acids with a carrier agent to form a delivery complex solution, applying the delivery complex solution to a substrate, and applying a polymeric solution to the substrate. In another embodiment, the invention includes a method of making a medical device including complexing nucleic acids with a carrier agent to form nucleic acid delivery complexes, combining the nucleic acid delivery complexes with a polymer solution and a cross-linking agent, wherein the cross-linking agent is positively charged or charge neutral.